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abstract Distinct inward-rectifier K+ channel subunits were ex- 
pressed in Xenopus oocytes and tested for their sensitivity to the 
channel blocker quinidine. The ‘strong’ inward-rectifier K+ chan- 
nel IRK1 was inhibited by quinidine with an EC5,, of 0.7 mM, 
while the ‘weak’ rectifier channel ROMKl was only moderately 
inhibited. ROMKI(N171D)-IRKlc_ter, chimeric channels, which 
carry both sites for strong rectification of IRK1 channels (the 
negatively charged D171 in the second transmembrane domain 
and the IRKl-C-terminus including E224), displayed strong recti- 
ticatlon like IRK& but showed weak sensitivity to quinidine-like 
KOMKl, suggesting independence of quinidine binding and recti- 
tication mechanisms. Moreover, BIRlO and BIRll, two strong 
rectifier subunits originally cloned from rat brain, exerted sub- 
unit-specific sensitivity to quinidine, being much higher for 
HIRll. Qulnldine blockade of IRK1 was not voltage-dependent, 
hut strongly dependent on the pH in the superfusate. These results 
*trongly suggest a subunit-specific interaction of inward-rectifier 
K+ channels with neutral quinidine within membrane lipid bilay- 
tars. 
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I. Introduction 
Inward rectifying Kf channels determine the resting poten- 
ial in many excitable and nonexcitable cells [l]. Recently, the 
irst genes encoding inward-rectifying K’ channels, ROMK 1 
md IRKI, were successfully cloned [2,3]. These two channels 
:xhibit distinct rectification properties, which may be ‘strong’ 
)r ‘weak’ [l]. The strong rectification of IRK1 is due to a high 
affinity, voltage-dependent block by intracellular polyamines 
4-71, while the weak rectification observed in ROMKl chan- 
lels corresponds to a much lower affinity of these channels to 
.>olyamines [5]. In contrast to physiologically relevant polyam- 
nes, specific effects of xenobiotics on distinct inward-rectifier 
K’ channels have not been described. Such xenobiotics could 
3e used to distinguish pharmacologically between differentially 
Jomposed inward-rectifier K’ channels. Therefore, the aim of 
he present study was to analyze strong and weak rectifiers for 
heir sensitivity to the antiarrhythmic drug quinidine. For that 
>urpose, the strong rectifiers IRK], BIRlO and BIRl 1 [3,8] and 
he weak rectifier ROMKI [2] were expressed in Xenopus 
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oocytes and tested for their sensitivity to the ion channel 
blocker quinidine. 
2. Materials and methods 
Handling and injection of Xenopus oocytes and synthesis of cRNA 
has been described previously in detail [9]. Electrophysiological record- 
ings were performed three to seven days after injection using a two- 
microelectrode voltage-clamp. Current- and voltage-electrodes were 
pulled from thick-walled borosilicate glass, had resistances between 0. I 
and 0.5 MQ and were filled with 3 M KCI. Currents were recorded with 
a TurboTec OlC amplifier (npi, Tamm, Germany), digitized at 0.1 kHz 
(ITCl6, HEKA, Lamprecht, Germany) and stored on harddisk. The 
bath chamber was made up as a narrow canal to achieve complete 
solution exchanges in less than 3 s. The basic solution (KFR*) was 
composed as follows (in MM): KC1 90, NaC127.5, CaClz 1.8, HEPES 
10; pH was adjusted to 7.2. For some experiments this solution was 
titrated to pH 6.0 and 8.0 using HCl and NaOH, respectively. Quinidine 
was purchased from Sigma and dissolved in KFR* to yield the final 
concentrations indicated. All experiments were performed at room tem- 
perature (approximately 23°C). Data are presented as mean ? standard 
error (S.E.M.), n represents the number of experiments performed. A 
Student’s t-test was used to test for statistical significance, which was 
obtained for P < 0.05. 
The mutant channel RO-IR,(NI’JlD) was constructed by a three 
step polymerase chain reaction (PCR) using ROMKl(Nl7lD) and 
IRK1 as templates: in a first step, a fragment ranging from 5’-UT to 
amino acid (aa) 17 I (last aa of the proposed TM2, according to [3]) of 
ROMK(N 17lD), previously prepared according to [lo], was amplified 
using the following primers (5’-GGCAGGGATCCATTGCTTGCT- 
TTG-3’, bp -31 to -7; and 5’-GGCACCACACATGAAGGAATTG- 
ATG-3’, bp 507 to 531). 
In a second PCR, a fragment of IRK1 ranging from the first aa 
C-terminal to TM2 to aa 319 (in the C-terminus) was amplified using 
the following primers (S-CATCAATTCCTTCATGTGTGGTGCC- 
GTCATGGCGAAGATGGCAAA-3’ corresponding to bp 507 to 53 1 
of ROMKl + bp 534 to 553 of IRKl; and 5’-CTCTTTCGAAGGT- 
TACCCAC-3’. bp 639 to 658 bp of IRKl). Both fragments were then 
used as templates for the third PCR with the upper primer of the first 
and the lower primer of the second PCR as primers. The final PCR- 
product was digested and subcloned into an IRK1 clone previously 
inserted into a pSP64T-derived vector. The entire construct was se- 
quenced and verified as RO-IR,(N171D). 
3. Results 
Application of the antiarrhythmic drug quinidine to oocytes 
previously injected with IRKl-specific cRNA resulted in inhi- 
bition of IRKI-mediated currents by 61.3 f 9.2% (n = 5). The 
quinidine-mediated inhibition was mostly reversible upon an 
extended washout (10 min). Subsequently, the effects of quini- 
dine were analyzed in detail on the strong and weak rectifier- 
channels IRK1 and ROMKl. While IRKl-mediated currents 
were inhibited with an EC,, of 0.71 ? 0.08 mM (Fig. lA,D; 
n = 5), ROMKl-mediated currents were decreased by only 
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Fig. 1. Quinidine(quin)-mediated inhibition (at 1 mM) of the strong and weak inward-rectifier K’ channels IRK1 (A), ROMKl (B) and RO- 
IR,(N171D) mutant channels (C). Currents were recorded during voltage ramps from -100 to 50 mV (3.75 s) from. The holding potential was 
0 mV. (D) Dose-response curves of quinidine-mediated inhibition of IRKl, ROMKl and RO-IRc(N171D) channels, respectively. Data are given 
as mean f S.E.M. 
25.0 + 16.0% (Fig. lB,D; n = 5) by application of 1 mM quini- nants of strong rectification of IRK 1: the C-terminus [ 1 l] and 
dine, suggesting interference between rectification and quini- an aspartate residue at amino acid position 171 [12-141. As 
dine-induced current inhibition. To check for such interfer- expected, this mutant displayed strong rectification similar to 
ence a chimeric channel ROMKl(Nl71D)-IRKlc,,, (RO- IRK1 (Fig 1C). However, the sensitivity of RO-IRc(N171D) 
IRc(N171D)) was constructed, which carries both determi- for quinidine was similar to that observed for ROMKl chan- 
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I ‘ig. 2. Quinidine-mediated inhibition (at 1 mM) of the strong rectifier 
K’ channels BIRlO (A) and BIRll (B). (C) Doseeresponse curve for 
%.uinidine-mediated inhibition of BIRlO and BIRll. Data are given as 
“lean + S.E.M. 
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nels (Fig. ID). This suggests independence of quinidine sensi- 
tivity and rectification and more likely points to a subunit- 
specific interaction of the xenobiotic with inward-rectifier K’ 
channels. 
The inhibitory effect of quinidine was therefore further inves- 
tigated in the inward-rectifier subunits BIRlO and BIRIl, 
which were originally cloned from rat brain and display strong 
rectification [8]. BIRll channels were inhibited by quinidine 
with an EC,, value similar to that obtained for IRK1 
(0.58 ? 0.06 mM (Fig. 2A,C; n = 5)) while no significant inhibi- 
tion was observed for BIRlO channels (Fig. 2B,C; n = 5), sup- 
porting the subunit-specificity of quinidine-channel-interac- 
tion. 
Subsequently the mechanism of quinidine blockade was fur- 
ther investigated. In a first set of experiments the quinidine 
inhibition of IRK1 and ROMKl was analyzed for its voltage- 
dependence. For both K’ channel subtypes the extent of quini- 
dine (1 mM) blockade of inward K’ currents measured at 
voltage steps to - 100 mV, -70 mV and -40 mV (holding 
potential was 0 mV). Although there was a tendency to a more 
pronounced block at more depolarized potentials, the observed 
blockade was not significantly different at these voltages (data 
not shown; n = 6 for both IRK1 and ROMKl). 
In another set of experiments, the effects of quinidine on 
IRK1 and ROMKl were compared with quinine, a stereo- 
isomer of quinidine. Quinine (1 mM) inhibited both channels 
with a smaller potency compared to quinidine (Fig. 3A; n = 5). 
The quinidine molecule comprises two basic groups with 
pK,s of 5.4 and 10, respectively. Therefore, the effects of ex- 
tracellular pH on quinidine-mediated inhibition of IRK1 was 
analyzed at pH 6 and 8. At pH 8 approximately 1% of quinidine 
is in its neutral form and 99% carry a single positive charge, 
( w 
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!Gg. 3. (A) Comparison of inhibition mediated by quinidine (black columns) and quinine (white columns) at a concentration of 1 mM on IRK1 and 
!<OMKl channels. (B) pH-dependence of quinidine effects on IRKl. Data are given as mean ? S.E.M. 
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while at pH 6.0 there is virtually no neutral quinidine, 80% 
carry a single positive charge and 20% are twofold positively 
charged. As shown in Fig. 3B, at pH 8.0 quinidine (1 mM) 
inhibited IRK1 channels much stronger (88.3 f 1.5%; n = 5) 
than at pH 6 (13.6 + 3.7%; n = 5). 
4. Discussion 
The aim of the present study was to search for pharmacologi- 
cal agents, which can distinguish between distinct inward-recti- 
fier K’ channels. Indeed, a subunit-specific sensitivity of in- 
ward-rectifier K’ channels was found for the antiarrhythmic 
quinidine. Quinidine at a concentration of 1 mM strongly inhib- 
ited IRK1 and BIRll channels, while ROMKl, BIRlO and 
RO-IRc(N171D) were almost unaffected. 
All these subunits display either weak or strong rectification 
properties according to their differential sensitivity to intracel- 
lular polyamines [5], and an involvement of the binding site for 
polyamines in quinidine blockade was first hypothesized. How- 
ever, a number of results refute such a mechanism. First, muta- 
tions found to increase sensitivity of ROMKl channels to pol- 
yamines indeed increased its rectification, however, they failed 
to increase sensitivity to quinidine. Second, binding of quini- 
dine molecules in their protonated form to a binding site within 
the transmembrane electrical field would be expected to be 
voltage-dependent, as found for the polyamine block. How- 
ever, quinidine-mediated inhibition of inward currents through 
IRK1 and ROMKl was not significantly different between 
-100 and -40 mV. Finally, the three strong rectifiers IRKl, 
BIR 10 and BIRl 1 displayed a distinct quinidine sensitivity, 
although their sensitivity to intracellular polyamines is almost 
identical. Thus it may be concluded, that quinidine binds to a 
site of the channel which is different from the polyamine bind- 
ing site. 
Instead, two results indicate a hydrophobic interaction of 
quinidine with the channel protein. First, quinidine blockade 
is virtually voltage-independent. Second and of greater signifi- 
cance, the strong pH-dependence of quinidine supports the 
hypothesis that the neutral form of quinidine predominantly 
interacts with the channel protein via hydrophobic binding. It 
is also possible that quinidine reaches its binding site at the 
channel protein via a two-step membrane pathway, as has been 
reported for dihydropyridine binding to L-type calcium chan- 
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nels [IS]. In this event, the neutral form of quinidine is more 
likely to enter the bulk lipid phase and to reach the binding site 
on the channel protein via lateral diffusion. 
In summary, quinidine inhibits inward-rectifier K’ channels 
in a subunit-specific manner, which is unrelated to the mecha- 
nisms involved in inward-rectification. Thus, quinidine sensitiv- 
ity may serve as an independent tool to discriminate between 
inward-rectifier subtypes. However, the specific mechanism of 
inhibition and site of quinidine binding remains elusive. 
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